Staff Profile

Dr Othman Al Musaimi assumed the role of Lecturer in Medicinal Chemistry at the School of Pharmacy in September 2023. Before joining this position, he worked as a Research Associate at Imperial College London. Dr Al Musaimi holds a PhD in Pharmaceutical Chemistry from the University of Kwazulu-Natal in South Africa. His research interests primarily revolve around the development of synthetic, separation, and purification methodologies for peptides.

Professional Affiliations

• Honorary Associate Fellow.
• Translational and Clinical Research Institute Fellow.
• Community Associate, ACS.
• UKRI Talent Peer Review College Member.
• European Peptide Society (EPS).
• Royal Society of Chemistry Affiliate.
• American Peptide Society (APS).

Academic roles

• Academic Lead for Peer Mentoring

Othman's research interests focus on developing synthetic, separation, and purification methodologies for peptides.

Funds

2024

• Adventurous Manufacturing Grant - Round 3: EPSRC: Co-I

2024

• Research Excellence Development Award: Newcastle University: PI

2023   

• Seed Fund: Imperial College London: PI
• Deep Technology Prime: Imperial College London: PI

2021

• Julia Higgins Engineering Postdoc Collaborative Research Fund: Imperial College London: Co-I

2022

• Dame Julia Higgins Engineering Postdoc Collaborative Research Fund: Imperial College London: PI

2015

• Research & Development Grant: King Abdulaziz City for Science and Technology (KACST): PI

Awards

• Unsung Heroes - Advancement of Knowledge Winner - C-DICE, the Centre for Postdoctoral Development in Infrastructure Cities and Energy
• Creating a Positive Research Environment Winner - Imperial College London
• Departmental Team Gold Award Winner - Department of Chemical Engineering - Imperial College London

Links

Google Scholar: https://scholar.google.com/citations?hl=en&user=3Di2QicAAAAJ

Research Gate: https://www.researchgate.net/profile/Othman-Al-Musaimi

LinkedIn: https://www.linkedin.com/in/othman-al-musaimi-phd-88619613/

Stage 1

• Acid-base 1-2
• Acid-base 3-4
• Thermodynamics 1
• Thermodynamics 2
• Thermodynamics 3

Stage 2

• Antibiotic Chemistry
• Mini Project Tutorial 1
• Case study - GI drugs
• Physicochemical Properties 1
• Physicochemical Properties 2
• Salbutamol/Salmeterol
• Mini Project Tutorial 2
• Synthesis 1
• Mini Project Tutorial 3
• Synthesis 2
• Mini Project Drop in 2
• Drug Likeness and Drugability

Stage 3

• Chemistry of sildenafil: case study

Stage 4

• Mechanistic basis of antibacterial therapy
• Antibacterial chemistry seminar
• Mechanistic basis of chemotherapy 1
• Mechanistic basis of chemotherapy 2
• Mechanistic basis of chemotherapy 3
• PARP inhibitors
• Chemotherapy chemistry seminar
• Development of TKIs

• Articles

  • Zulfiqar N, Nadeem R, Al Musaimi O. Photocatalytic Degradation of Antibiotics via Exploitation of a Magnetic Nanocomposite: A Green Nanotechnology Approach toward Drug-Contaminated Wastewater Reclamation. ACS Omega 2024, 9(7), 7986-8004.
  • Al Musaimi, O. Exploring FDA-Approved Frontiers: Insights into Natural and Engineered Peptide Analogues in the GLP-1, GIP, GHRH, CCK, ACTH, and α-MSH Realms. Biomolecules 2024, 14(3), 264.
  • Al Musaimi O, Al Shaer D, Albericio F, de la Torre BG. 2023 FDA TIDES (Peptides and Oligonucleotides) Harvest. Pharmaceuticals 2024, 17(2), 243.
  • Al Musaimi O, Morse SV, Lombardi L, Serban S, Basso A, Williams DR. Successful synthesis of a glial-specific blood–brain barrier shuttle peptide following a fragment condensation approach on a solid-phase resin. Peptide Science 2023, 29(2), e3448.
  • Gavva V, Al Musaimi O, Bent C, Williams DR. Determining the Hydrophobicity Index of Protected Amino Acids and Common Protecting Groups. Separations 2023, 10(8), 456.
  • Al Musaimi O, Gavva V, Williams DR. Greener Cleavage of Protected Peptide Fragments from Sieber Amide Resin. ChemistryOpen 2022, 11(12), e202200236.
  • Al Musaimi O, Al Shaer D, Albericio F, de la Toree BG. 2020 FDA TIDES (Peptides and Oligonucleotides) Harvest. Pharmaceuticals 2021, 14(2), 145.
  • Al Musaimi, O. Greening Fmoc/tBu solid-phase peptide synthesis. Green Chemistry 2020, 22, 996-1018.
  • Al Shaer D, Al Musaimi O, Albericio F, de la Toree B G. 2019 FDA TIDES (peptides and oligonucleotides) harvest. Pharmaceuticals 2019, 13(3), 40.

• Patent

  • Al Musaimi, O. Methods of Chemical Synthesis of Peptides. UK, GB2312735.0, 2023. Submitted.